You searched for sdna-1000 » Spectrum Solutions

2202, 2023

FDA 510(k) Class II Medical Device Clearance for SDNA Saliva Collection Device

By Bryant|2023-12-15T04:26:18+00:00February 22nd, 2023|Categories: #spitMatters, Clinical Solutions, COVID-19, IVD Commercialization Solutions, Medical Science, NEWS, Product Innovations, Saliva Diagnostics|Tags: #partofthesolution, #spitMatters, 510k, FDA Clearance, IVD medical device, microarray diagnostics, multi omic analysis, multiplex testing, nucleic acid preservation, Saliva Collection Device, saliva diagnostic testing, Saliva DNA Collection, saliva IVD, saliva screening, saliva test, salivary diagnostics|Comments Off on FDA 510(k) Class II Medical Device Clearance for SDNA Saliva Collection Device

SDNA Saliva Collection FDA 510(k) Class II Medical Device Clearance PRESS RELEASE Leslie Titus Bryant February 22, 2023 SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced the U.S. Food and Drug Administration (FDA) has granted 510(k)

2510, 2022

Dr. Wong of UCLA to Present Collection Advantage in Saliva Liquid Biopsy at ASHG

By Bryant|2023-12-15T04:28:17+00:00October 25th, 2022|Categories: #partoftheSolution, #spitMatters, Biosample Collection, Dental Medicine, Diagnostics-at-Home, Discovery, Detection, & Diagnosis, Liquid Biopsy, Medical Science, NEWS, Product Innovations, Research Collaboration, Saliva Diagnostics, Saliva IVD Medical Devices|Tags: #partofthesolution, #spitMatters, amplifying DNA, ASHG, bench to bedside, BIO Journal, cancer biomarkers, CDx, circulating tumor DNA, clinical diagnostics, clinical laboratory science, clinical testing, CV3, David T.W. Wong, DNA Testing, Dr. Wong, early cancer detection, EFIRM, EGFR, healthcare, healthcare at home, hospital at home, Human Genetics, in vitro diagnostics, IVD, IVD clinical solutions, IVD medical device, IVD Medical Science, IVD research study, laboratory medicine, laboratory science, liquid biopsy, lung cancer, Molecular Diagnostic Testing, non-invasive specimen collection, non-small cell lung cancer, NSCLC, precision medicine, preservation, saliva cancer testing, saliva diagnostic research, saliva diagnostics, salivary diagnostics, specialized testing kits, specimen collection, Spectrum Solutions, spit test, stability, UCLA, UCLA School of Dentistry, ultra short ctDNA, Utah Life Sciences|Comments Off on Dr. Wong of UCLA to Present Collection Advantage in Saliva Liquid Biopsy at ASHG

Dr. David Wong of UCLA to Present Saliva Liquid Biopsy Research Findings with Collection Advantages at ASHG 2022 PRESS RELEASE Leslie Titus Bryant October 25, 2022 SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced David T.W.

2906, 2022

Saliva Research Highlights DNA Amplifying Ability and Clear Detection of Cancer Biomarkers

By Bryant|2023-12-15T04:29:16+00:00June 29th, 2022|Categories: #spitMatters, Biosample Collection, Clinical Solutions, Compounding Rx, Diagnostics-at-Home, Discovery, Detection, & Diagnosis, Dx to Rx, Healthcare-at-Home, IVD Assay Development, Liquid Biopsy, Medical Science, NEWS, Product Innovations, Remote Healthcare Solutions, Saliva Diagnostics, Saliva IVD Companion Diagnostics|Tags: #partofthesolution, #spitMatters, amplifying DNA, cancer biomarkers, CDx, circulating tumor DNA, clinical diagnostics, clinical kitting, commercial kitting, companion diagnostics, complementary diagnostics, COVID, ctDNA, direct to consumer test kits, direct to patient, Dx to Rx, early detection, EFRIM, EGFR, FLU a, FLU b, gene mutations, healthcare, healthcare at home, hospital at home, in vitro diagnostics, Infectious Disease, ISBER, IVD, IVD clinical solutions, IVD medical device, IVD Medical Science, IVD research study, liquid biopsy, Molecular Diagnostic Testing, multiplex testing, Next-Gen Sequencing, PCR tests, point of need, protein testing, remote care, remote healthcare, RSV, saliva diagnostics, saliva IVD, saliva screening, saliva test, SARS, screening, specialized testing kits, specimen collection, Spectrum Solutions, spit test, ultra short ctDNA, Utah Life Sciences|Comments Off on Saliva Research Highlights DNA Amplifying Ability and Clear Detection of Cancer Biomarkers

Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers PRESS RELEASE Leslie Titus Bryant July 26, 2022 SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced the publishing

2705, 2022

The COVID-19 -20 -21 -2022 Predictable Backslide

By Bryant|2023-12-15T04:31:36+00:00May 27th, 2022|Categories: #spitMatters, Clinical Solutions, COVID-19, Diagnostics-at-Home, Healthcare-at-Home, Infectious Disease, Medical Science, NEWS, Remote Healthcare Solutions, Saliva Diagnostics, Saliva IVD Medical Devices|Tags: #partofthesolution, #spitMatters, CDx, clinical diagnostics, clinical kitting, commercial kitting, companion diagnostics, complementary diagnostics, COVID, direct to consumer test kits, direct to patient, Dx to Rx, early detection, FLU a, FLU b, healthcare, healthcare at home, hospital at home, in vitro diagnostics, Infectious Disease, ISBER, IVD, IVD clinical solutions, IVD medical device, IVD Medical Science, IVD research study, Molecular Diagnostic Testing, multiplex testing, Next-Gen Sequencing, PCR tests, point of need, remote care, remote healthcare, RSV, saliva diagnostics, saliva IVD, saliva screening, saliva test, SARS, screening, specialized testing kits, specimen collection, Spectrum Solutions, spit test, Utah Life Sciences|Comments Off on The COVID-19 -20 -21 -2022 Predictable Backslide

The COVID-19, 20, 21, 2022 Predictable Backslide Leslie Titus Bryant May 25, 2022 If we’ve learned anything from this COVID pandemic it should be: the value of early detection and the importance of accurate testing The

501, 2022

Saliva Testing Brings Major League Baseball Back

By Bryant|2023-12-15T04:35:11+00:00January 5th, 2022|Categories: #partoftheSolution, #spitMatters, 3PL Logistics & Fulfillment, Biosample Collection, Clinical Solutions, COVID-19, Customer Kudos, Diagnostics-at-Home, Discovery, Detection, & Diagnosis, Healthcare-at-Home, Infectious Disease, Medical Science, NEWS, Product Innovations, Remote Healthcare Solutions, Saliva Diagnostics, Saliva IVD Medical Devices, Solution Case Studies|Tags: #partofthesolution, #spitMatters, Case Study, CDx, clinical diagnostics, companion diagnostics, COVID, Dx to Rx, early detection, FLU a, FLU b, healthcare, healthcare at home, hospital at home, in vitro diagnostics, Infectious Disease, ISBER, IVD, IVD medical device, IVD Medical Science, IVD research study, Major League Baseball, Molecular Diagnostic Testing, multiplex testing, Next-Gen Sequencing, PCR tests, remote healthcare, RSV, saliva diagnostics, saliva IVD, saliva screening, saliva test, SARS, screening, specialized testing kits, specimen collection, Spectrum Solutions, spit test, Utah Life Sciences|Comments Off on Saliva Testing Brings Major League Baseball Back

Saliva Testing Innovation Brings MLB Back to the Game CASE STUDY Leslie Titus Bryant JAN 05, 2022 THE CHALLENGE: In the wake of the COVID-19 2020 global pandemic, the world’s economy slowed to a crawl, office buildings

1910, 2021

FDA Authorizes New Saliva Collection Method for COVID-19 Testing Plus Variants

By Bryant|2023-12-15T04:38:02+00:00October 19th, 2021|Categories: #partoftheSolution, Clinical Solutions, COVID-19, NEWS|Tags: #partofthesolution, #spitMatters, Amplitude Solution, back in class COVID testing, BioHive, BioUtah, cancer research study, cancer testing, cancer testing innovation, cell-free circulating tumor, ctDNA, diagnosis, diagnostic cancer testing, DNA collection, Dr. Wong, early detection, healthcare, k-12 COVID Testing, k12 testing program, liquid biopsy, Little League International, lung cancer, Major League Baseball, MiLB, Minor League Baseball, MLB, Molecular Diagnostic Testing, non-small cell lung cancer, NSCLC, PCR tests, personalized medicine, precision medicine, Regulatory Compliance, risk assessment, saliva cancer testing, Saliva Collection, Saliva Collection Device, saliva diagnostic testing, saliva diagnostics, saliva test, Saliva vs. Swabs, Saliva-Based Next-Gen Sequencing, SARS, screening, Spectrum DNA, Spectrum Solutions, spit test, Thermo Fisher, UCLA, UCLA research study, UCLA School of Dentistry, usctDNA, Utah Life Sciences|Comments Off on FDA Authorizes New Saliva Collection Method for COVID-19 Testing Plus Variants

NEW Thermo Fisher + Spectrum SDNA-1000 Saliva Collection Method Increases COVID-19 PCR Testing Capacity to 8000 Per Day Press Release Thermo Fisher October 20th, 2021 Thermo Fisher Scientific received emergency use authorization from the U.S. Food and Drug

1908, 2021

PCR vs. Rapid Antigen Lateral Flow COVID-19 Testing

By Bryant|2022-05-31T21:05:13+00:00August 19th, 2021|Categories: (2) Testing & Results|0 Comments

Early detection of SARS-CoV-2 infection is critical to reducing the asymptomatic and pre-symptomatic spread of COVID-19. PCR testing is still considered by the FDA and CDC to be the “gold standard”. It is a more sensitive, accurate, and reliable

1908, 2021

Unsupervised Sample Self-Collection Granted Authorized by the FDA

By Bryant|2022-05-31T21:07:24+00:00August 19th, 2021|Categories: (1) SDNA-1000 Device|0 Comments

Based on the totality of scientific evidence the FDA authorization has validated the Spectrum SDNA-1000's effectiveness in diagnosing COVID-19 by serving as a successful, noninvasive means to collect, neutralize, stabilize, and transport testing samples post-collection at ambient temperatures for

2007, 2021

Spectrum Solutions Named Official Testing Partner for Little League® Region and World Series

By Bryant|2023-12-15T04:43:37+00:00July 20th, 2021|Categories: #partoftheSolution, COVID-19, IVD Commercialization Solutions, NEWS, Product Innovations, Solution Case Studies, Uncategorized|Tags: #partofthesolution, #spitMatters, BioHive, BioUtah, cancer research study, cancer testing, cancer testing innovation, cell-free circulating tumor, ctDNA, diagnosis, diagnostic cancer testing, DNA collection, Dr. Wong, early detection, healthcare, liquid biopsy, Little League International, lung cancer, Major League Baseball, MiLB, Minor League Baseball, MLB, Molecular Diagnostic Testing, non-small cell lung cancer, NSCLC, PCR tests, personalized medicine, precision medicine, Regulatory Compliance, risk assessment, saliva cancer testing, Saliva Collection, Saliva Collection Device, saliva diagnostic testing, saliva diagnostics, saliva test, Saliva vs. Swabs, Saliva-Based Next-Gen Sequencing, SARS, screening, Spectrum DNA, Spectrum Solutions, spit test, UCLA, UCLA research study, UCLA School of Dentistry, usctDNA, Utah Life Sciences|Comments Off on Spectrum Solutions Named Official Testing Partner for Little League® Region and World Series

Spectrum Solutions Named Official Testing Partner for Little League® Region and World Series Tournaments PRESS RELEASE Little League International July 20th, 2021 This July and August, Little League® and Spectrum Solutions, LLC are teaming up to be part of the

1006, 2021

Saliva Diagnostic Liquid Biopsy

By Bryant|2023-07-18T15:49:23+00:00June 10th, 2021|Comments Off on Saliva Diagnostic Liquid Biopsy

Saliva Liquid Biopsy Clinical Laboratory Medicine Innovation Stabilize, Preserve, & Amplify DNA Signal at the Point of Collection for Noninvasive Genomic, Epigenomic, & Proteomic Testing Saliva Liquid Biopsy Clinical Laboratory Medicine

You searched for : sdna-1000

Spectrum Solutions

Spectrum Laboratory

Spectrum Manufacturing

Spectrum Compounding RX